These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 15289324)
1. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation. Gattelli A; Cirio MC; Quaglino A; Schere-Levy C; Martinez N; Binaghi M; Meiss RP; Castilla LH; Kordon EC Cancer Res; 2004 Aug; 64(15):5193-9. PubMed ID: 15289324 [TBL] [Abstract][Full Text] [Related]
2. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Hollmann CA; Kittrell FS; Medina D; Butel JS Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642 [TBL] [Abstract][Full Text] [Related]
3. Pregnancy-dependent to ovarian-independent progression in mammary tumors delineated in primary culture: changes in signal transduction, growth factor regulation, and matrix interaction. Imagawa W; Bandyopadhyay GK; Garcia M; Matsuzawa A; Nandi S Cancer Res; 1992 Dec; 52(23):6531-8. PubMed ID: 1330295 [TBL] [Abstract][Full Text] [Related]
4. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853 [TBL] [Abstract][Full Text] [Related]
5. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors. Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624 [TBL] [Abstract][Full Text] [Related]
6. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177 [TBL] [Abstract][Full Text] [Related]
7. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Kitsberg DI; Leder P Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125 [TBL] [Abstract][Full Text] [Related]
8. Metallothionein expression and apoptosis in pregnancy-dependent and -independent mouse mammary tumors. Yamamura Y; Ohta Y; Iguchi T; Matsuzawa A Anticancer Res; 2001; 21(2A):1145-9. PubMed ID: 11396154 [TBL] [Abstract][Full Text] [Related]
9. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones. Matsuzawa A; Kaneko T; Ikeda Y Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452 [TBL] [Abstract][Full Text] [Related]
10. Association of hst gene expression with metastatic phenotype in mouse mammary tumors. Murakami A; Tanaka H; Matsuzawa A Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796 [TBL] [Abstract][Full Text] [Related]
11. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha. Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494 [TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines. Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949 [TBL] [Abstract][Full Text] [Related]
13. Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors. Roelink H; Wagenaar E; Nusse R Oncogene; 1992 Mar; 7(3):487-92. PubMed ID: 1549363 [TBL] [Abstract][Full Text] [Related]
14. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Callahan R; Smith GH Oncogene; 2000 Feb; 19(8):992-1001. PubMed ID: 10713682 [TBL] [Abstract][Full Text] [Related]
15. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice. Lane TF; Leder P Oncogene; 1997 Oct; 15(18):2133-44. PubMed ID: 9393971 [TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of immortalized non-transplantable mouse mammary cell lines cloned from a MMTV-induced tumor cell line cultured for a long duration. Takenaka T; Saga S; Miyaishi O; Imai M; Yokoi T; Lu J; Wajjwalku W; Kusakabe M; Taguchi O; Matsuyama M Nagoya J Med Sci; 1991 Mar; 53(1-4):9-21. PubMed ID: 1666666 [TBL] [Abstract][Full Text] [Related]
17. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice. Kapoun AM; Shackleford GM Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106 [TBL] [Abstract][Full Text] [Related]
18. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320). Takeda Y; Matsuzawa A; Kaneko T; Sekiguchi M; Fujii G Jpn J Exp Med; 1988 Apr; 58(2):87-98. PubMed ID: 2842525 [TBL] [Abstract][Full Text] [Related]
19. Origin and progression of pregnancy-dependent mammary tumors induced by new mouse mammary tumor virus variants. Buggiano V; Levy CS; Gattelli A; Cirio MC; Marfil M; Nepomnaschy I; Piazzon I; Helguero L; Vanzulli S; Kordon EC Breast Cancer Res Treat; 2002 Oct; 75(3):191-202. PubMed ID: 12353808 [TBL] [Abstract][Full Text] [Related]
20. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]